COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 135 filers reported holding COGENT BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,670,628 | -17.7% | 4,684,167 | +0.0% | 4.81% | -45.8% |
| Q2 2023 | $55,460,123 | +5.2% | 4,684,132 | -4.1% | 8.87% | -13.8% |
| Q1 2023 | $52,708,902 | +12.9% | 4,884,977 | +21.0% | 10.29% | +30.9% |
| Q4 2022 | $46,680,633 | -22.5% | 4,038,117 | 0.0% | 7.86% | -15.4% |
| Q3 2022 | $60,249,000 | +65.4% | 4,038,117 | 0.0% | 9.30% | +29.6% |
| Q2 2022 | $36,424,000 | +346.6% | 4,038,117 | +270.9% | 7.17% | +443.0% |
| Q1 2022 | $8,155,000 | -12.7% | 1,088,817 | 0.0% | 1.32% | +3.4% |
| Q4 2021 | $9,342,000 | +2.0% | 1,088,817 | 0.0% | 1.28% | +8.6% |
| Q3 2021 | $9,157,000 | +3.7% | 1,088,817 | 0.0% | 1.18% | +9.8% |
| Q2 2021 | $8,830,000 | -7.6% | 1,088,817 | 0.0% | 1.07% | +3.3% |
| Q1 2021 | $9,560,000 | -21.8% | 1,088,817 | 0.0% | 1.04% | -42.3% |
| Q4 2020 | $12,227,000 | – | 1,088,817 | – | 1.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |